Finding studies

Clareo Health | Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis

Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study